BioWorld

Oct. 8, 2002

McClellan Breezes Through First Meeting Before Senate Committee

WASHINGTON - Nominee Mark McClellan easily jumped the first hurdle in becoming the next commissioner of the FDA from a largely absent Senate committee. (Bioworld Today) Read More

New Erbitux Trials Starting; ImClone Has Second Chance'

Phylogeny Test Opens Novel Path To Forensic Crime Detection, First In U.S.; Forecast As Future Model

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for April 6, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026

Hengrui discovers new Nav1.8 blockers

BioWorld Science

Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...

Hematopoietic stem cell research points to leukemia’s early roots

BioWorld Science

Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...

Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

BioWorld Science

Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...